ArticleJournal of hematology & oncology2023

A pH-dependent anti-CD47 antibody that selectively targets solid tumors and improves therapeutic efficacy and safety.

Yulu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.